Navigation Links
European Commission Designates MST-188 As An Orphan Medicinal Product
Date:3/25/2013

SAN DIEGO, March 25, 2013 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that the European Commission (EC) has designated MST-188 as an orphan medicinal product for the treatment of sickle cell disease.  This decision follows a positive opinion adopted by the Committee for Orphan Medicinal Products (COMP) recommending such designation. 

Brian M. Culley , Chief Executive Officer, said: "Now that we actively are recruiting patients in EPIC, our pivotal phase 3 study of MST-188 in sickle cell disease, we intend to pursue strategic alliances more aggressively.  We believe orphan designation and the expectation of 10 years of marketing exclusivity in the EU will enhance partnering interest in Europe.  In addition to enabling development in multiple countries and enhancing the overall commercial opportunity for MST-188, partnerships will help fund its development within the U.S." 

Mr. Culley continued: "Our recently announced plans to investigate MST-188 in acute limb ischemia, a complication of peripheral arterial disease, also may bolster our partnering efforts.  Indeed, we already have been approached by at least one pharmaceutical company that wished to discuss our near- and long-term plans in arterial disease, which we announced just three weeks ago."

About Orphan Medicinal Product Designation

The COMP, one of seven scientific committees of the European Medicines Agency (EMA), is responsible for reviewing applications from companies seeking "orphan medicinal product designation" and making recommendations to the EC regarding these applications.  Orphan medicinal product designation is for investigational medicines designed to treat rare diseases that are life-threatening or chronically debilitating and for which there is no satisfactory method of treatment or, if such a method exists, for investigational medicines that
'/>"/>

SOURCE Mast Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
2. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
3. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
4. Blood Disorders: European Hematologists Gather in Amsterdam, June 14-17, 2012
5. Mylan Launches Generic Lipitor® in Five European Countries
6. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
7. Bristol-Myers Squibb to Present New Data on ORENCIA(R)? (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
8. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
9. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
10. Cardiac Dimensions® Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
11. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015  Landauer, Inc. (NYSE: ... environmental radiation measurement and monitoring, outsourced medical physics services ... will release financial results for the fiscal first quarter ... 2015. The Company will also host ... 2015 at 9:00 a.m. Central Time (10:00 a.m. Eastern ...
(Date:3/2/2015)... , March 2, 2015 Amgen (NASDAQ: ... 15 abstracts, including data evaluating Repatha TM (evolocumab), ... an investigational drug for chronic heart failure, at the ... Scientific Session (ACC.15), being held March 14-16 in ... a fully human monoclonal antibody that inhibits proprotein convertase ...
(Date:3/2/2015)... N.H. , March 2, 2015 /PRNewswire/ ... provider of professional-grade vitamins, supplements, prescription products ... announced a strategic partnership with Anabolic Laboratories, ... for healthcare professionals. This new partnership will ... into new licensed healthcare practitioner segments and ...
Breaking Medicine Technology:Landauer, Inc. Announces Date and Time for Announcement of Fiscal First Quarter 2015 Results and Conference Call 2Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 2Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 3Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 4Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 5Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 6Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 7Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 8Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 9Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 10Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 11Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 2Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 3
... 27 VirtualScopics, Inc. (Nasdaq: VSCP ), a ... announced that before the market opens on Thursday, November ... financial results. The company will host a conference call ... President and Chief Executive Officer, Jeff Markin, and Chief ...
... ARAY ), a global leader in the field of ... installed base has signed on to utilize Accuray,s Treatment Planning ... 10 percent of U.S. sites that had signed ... is designed to help customers maximize utilization of their CyberKnife ...
Cached Medicine Technology:VirtualScopics Schedules Third Quarter 2009 Earnings Announcement 2Accuray's Treatment Planning Service Active at 20 Percent of U.S. CyberKnife Centers 2Accuray's Treatment Planning Service Active at 20 Percent of U.S. CyberKnife Centers 3Accuray's Treatment Planning Service Active at 20 Percent of U.S. CyberKnife Centers 4
(Date:3/2/2015)... 02, 2015 Getting customers to discover ... the goal this March as the 31st annual Frozen ... the National Frozen & Refrigerated Foods Association (NFRA) to ... offers more than 20 delicious frozen selections and is ... The tasty frozen options are crafted with simple ingredients, ...
(Date:3/2/2015)... Today the Brain Injury Association of America (BIAA) officially ... and support the more than 5.3 million Americans who are ... the nation in observing Brain Injury Awareness Month by conducting ... for the 2015 to 2017 campaign is: Not Alone. ... the general public about the incidence of brain injury and ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Market Publishers ... reports worked out by Global Industry Analysts Inc and ... Equipment: Market Research Report . Through 2018, the global ... 6.04% CAGR. The detailed research report suggests a holistic ... radiation therapy equipment as well as covers the top ...
(Date:3/2/2015)... York, New York (PRWEB) March 02, 2015 ... Publisher of Idoll Magazine, a medium for the model ... patrons can find, and buy Mango, Passion Fruit, Pink ... Tuesday, March 3rd, 2015, after 1pm. , At a ... Cosmetics has recently came under fire by announcing the ...
(Date:3/2/2015)... 2015 After a rigorous evaluation process ... pricing and long-term strategy, Blood Centers of America (BCA) ... for member centers’ testing needs. , BCA, which comprises ... than 30 percent of the U.S. blood supply, made ... is committed to drive cost savings to members,” said ...
Breaking Medicine News(10 mins):Health News:Take a Fresh Look at Frozen with Ian’s 2Health News:Brain Injury Association of America Launches “Not Alone” Campaign for Brain Injury Awareness Month 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 3Health News:Sex Sells! A Newly Minted Organic Bodycare Brand Courts Controversy at a Cost 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3
... is a week since the US Court of Federal Claims, ... children who are faulting childhood vaccines containing thimerosal. Commentators ... able to establish a firm link between the vaccines in ... heard is that of Michelle Cedillos. Her parents, Theresa and ...
... the highest level of health boosting antioxidants which could ... disease to cancer -- shows latest research. ... central and northern Europe and northern Asia. Scientists have ... nutritious than other fruits like apples, strawberries, mangoes or ...
... According to a study in the June issue of ... medication etanercept does not appear to cause more infections ... skin disorder , usually requires long-term therapy, according to ... levels of tumor necrosis factor (TNF) are elevated in ...
... diabetes are still in a high risk category with absolutely ... advances in medical science have reduced cardiovascular diseases to quite ... not seem to apply to women with diabetes. ,The ... dropped dramatically over the last few decades. ,The proportion ...
... of Tennessee researcher has discovered an association between foie ... type of amyloid found in rheumatoid arthritis or tuberculosis. ... University of Tennessee Graduate School of Medicine in Knoxville, ... is the first evidence that a food product can ...
... published in PLoS Medicine shows that men can help ... activity. Serious fractures are common among older people and can ... is already recommended that women should take exercise to ... the bones with age is known as osteoporosis. Women are ...
Cached Medicine News:Health News:Autism Case Hearing Still to Produce Clinching Evidence on Vaccine Linkage 2Health News:Autism Case Hearing Still to Produce Clinching Evidence on Vaccine Linkage 3Health News:Autism Case Hearing Still to Produce Clinching Evidence on Vaccine Linkage 4Health News:Etanercept Reduces Psoriasis 2Health News:Diabetic Womens Death Rate Shows No Decline 2Health News:Scientists Establish Link Between Foie Gras and Disease 2Health News:Exercise Reduces Fracture in Men 2
... Urinalysis WorkCell System - A Single ... per hour, with true load-and-go productivity ... Clinitek Atlas and UF-100 for complete ... systems working together deliver utmost reliability. ...
... one of the 3 major naturally occurring ... In terms of estrogenic activity, estriol is ... is produced almost exclusively during pregnancy, and ... normal human fetus. During pregnancy, the production ...
... of the three major naturally-occurring estrogens. Other ... is produced primarily from androstenedione originating from ... In premenopausal adult women, more than 50% ... In prepubertal children, men and postmenopausal women, ...
... Estrone Enzyme Immunosorbent Assay (EIA) Kit ... of Estrone in serum. The procedure ... immunoassay where there is competition between ... antigen for a fixed number of ...
Medicine Products: